BSE Live
Jun 02, 16:01Prev. Close
639.75
Open Price
641.80
Bid Price (Qty.)
632.95 (1)
Offer Price (Qty.)
641.50 (23)
NSE Live
Jun 02, 15:47Prev. Close
640.55
Open Price
634.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Yearly Results of Eris Lifesciences (in Rs. Cr.) | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | |
Net Sales/Income from operations | 1,307.12 | 1,193.77 | 1,108.83 | 1,003.76 | 881.13 | |
Other Operating Income | 23.61 | 21.96 | -- | 16.47 | 15.41 | |
Total Income From Operations | 1,330.73 | 1,215.73 | 1,108.83 | 1,020.23 | 896.54 | |
EXPENDITURE | ||||||
Consumption of Raw Materials | 114.13 | 117.57 | 99.43 | 76.88 | 58.19 | |
Purchase of Traded Goods | 113.76 | 79.59 | 111.65 | 70.00 | 87.56 | |
Increase/Decrease in Stocks | 8.50 | 2.49 | -12.57 | 17.47 | -13.40 | |
Power & Fuel | -- | -- | -- | -- | -- | |
Employees Cost | 252.52 | 222.18 | 207.02 | 191.39 | 166.77 | |
Depreciation | 64.66 | 51.46 | 37.64 | 44.90 | 31.59 | |
Excise Duty | -- | -- | -- | -- | -- | |
Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
R & D Expenses | -- | -- | -- | -- | -- | |
Provisions And Contingencies | -- | -- | -- | -- | -- | |
Exp. Capitalised | -- | -- | -- | -- | -- | |
Other Expenses | 336.71 | 309.90 | 285.99 | 309.00 | 263.76 | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 440.46 | 432.54 | 379.67 | 310.59 | 302.07 | |
Other Income | 17.26 | 28.99 | 10.00 | 14.73 | 32.50 | |
P/L Before Int., Excpt. Items & Tax | 457.72 | 461.53 | 389.67 | 325.32 | 334.57 | |
Interest | 20.81 | 2.99 | 0.78 | 1.85 | 22.79 | |
P/L Before Exceptional Items & Tax | 436.91 | 458.54 | 388.89 | 323.46 | 311.78 | |
Exceptional Items | -- | -- | -- | -- | -- | |
P/L Before Tax | 436.91 | 458.54 | 388.89 | 323.46 | 311.78 | |
Tax | 38.90 | 41.35 | 38.29 | 32.71 | 26.40 | |
P/L After Tax from Ordinary Activities | 398.01 | 417.19 | 350.61 | 290.75 | 285.38 | |
Prior Year Adjustments | -- | -- | -- | -- | -- | |
Extra Ordinary Items | -- | -- | -- | -- | -- | |
Net Profit/(Loss) For the Period | 398.01 | 417.19 | 350.61 | 290.75 | 285.38 | |
Equity Share Capital | 13.60 | 13.59 | 13.58 | 13.58 | 13.75 | |
Reserves Excluding Revaluation Reserves | 2,208.29 | 1,904.51 | 1,561.89 | 1,286.12 | 1,142.26 | |
Equity Dividend Rate (%) | 735.00 | 601.00 | 550.00 | 287.00 | -- | |
EPS Before Extra Ordinary | ||||||
Basic EPS | 29.27 | 30.70 | 25.82 | 21.19 | 20.75 | |
Diluted EPS | 29.23 | 30.70 | 25.80 | 21.18 | 20.74 | |
EPS After Extra Ordinary | ||||||
Basic EPS. | 29.27 | 30.70 | 25.82 | 21.19 | 20.75 | |
Diluted EPS. | 29.23 | 30.70 | 25.80 | 21.18 | 20.74 | |
Public Share Holding | ||||||
No Of Shares (Crores) | -- | -- | -- | -- | -- | |
Share Holding (%) | -- | -- | -- | -- | -- | |
Promoters and Promoter Group Shareholding | ||||||
a) Pledged/Encumbered | ||||||
- Number of shares (Crores) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
b) Non-encumbered | ||||||
- Number of shares (Crores). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
- Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
17.05.2023
Eris Life Standalone March 2023 Net Sales at Rs 314.58 crore, up 11.5% Y-o-Y
17.05.2023
Eris Life Consolidated March 2023 Net Sales at Rs 402.80 crore, up 31.66% Y-o-Y
20.01.2023
Eris Life Consolidated December 2022 Net Sales at Rs 423.26 crore, up 27.43% Y-o-Y
20.01.2023
Eris Life Standalone December 2022 Net Sales at Rs 332.01 crore, up 8.99% Y-o-Y
17.01.2023
Eris Lifesciences Q3 PAT seen up 7.2% YoY to Rs 1,080 cr: Nirmal Bang
08.07.2022
Eris Lifesciences Q1 PAT seen up 4.3% YoY to Rs 111.3 cr: Prabhudas Lilladher
14.04.2022
Eris Lifesciences Q4 PAT seen up 30.7% YoY to Rs 89.2 cr: Prabhudas Lilladher
13.01.2022
Eris Lifesciences Q3 PAT seen up 12.4% YoY to Rs 101.4 cr: Prabhudas Lilladher